US Patent Issued to Bristol-Myers Squibb on Jan. 20 for "Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors" (Pennsylvania, Massachusetts, New Jersey Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,827, issued on Jan. 20, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Tricyclic heteroaryl-substituted quinoline and azaquinoline compounds as PAR4 inhibitors" was invented by Xiaojun Zhang (Furlong, Pa.), Eldon Scott Priestley (Yardley, Pa.), Oz Scott Halpern (Bordentown, N.J.), Wen Jiang (Furlong, Pa.), Samuel Kaye Reznik (Brookline, Mass.) and Jeremy M. Richter (Yardley, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds of Formula (I) to (VIII):or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate or prodrug thereof, wherein R3 is a tricyclic heteroaryl group substituted with R3a and zero t...